Head of Saxo Strats
Summary: We are updating our methodology on the bubble stocks basket introduced in early January as too many of the stocks had very high equity valuations but because they were strong companies. In this updated 'bubble stocks' basket we now require negative earnings expectations over the next 12 months. Many of the names are still the same, but a lot new ones have entered our list. If news or data begin to disappoint against expectations and interest rates continue to climb higher on more inflation, our reflation call for this year, then the most aggressively valued stocks could come under severe pressure.
Following our introduction of the reflation theme which we expect to dominate financial markets over the next 12-18 months, we talked about bubble stocks and introduced 40 stocks that had bubble like characteristics. While all 40 stocks are aggressively valued, some of them have high valuations due to industry specific characteristics (exchange and certain software companies). We have been thinking about the bubble stocks basket since and have chosen to update the methodology. Some of the stocks are the same, but many new stocks are on the list, but we think this list is much better.
Our selection universe is still stocks listed on the exchanges in North America, Western Europe, Japan, Hong Kong, Singapore, and Australia. We filter on market cap (above $ 2bn) and require that stocks have a negative 12-month forward expected earnings per share, and that the 12-month forward EV/Sales (enterprise value to sales) ratio is above 8. Our of an initial universe of 3,776 stocks (those with market cap above $2bn), 194 stocks have negative earnings expectations and a high equity valuation on their expected revenue. Of these stocks, we select the top 40 stocks on market cap (see list below).
| Name | Domicile | Mkt Cap (USD mn.) | 12M Fwd EPS | 12M Fwd EV/Sales | Diff to PT (%) |
| Kuaishou Technology | China | 213,499 | -0.85 | 16.2 | -14.2 |
| Sea Ltd | Singapore | 140,384 | -1.26 | 17.3 | -15.5 |
| Airbnb Inc | United States | 130,635 | -1.31 | 28.1 | -29.2 |
| NIO Inc | China | 94,795 | -1.59 | 18.0 | 7.9 |
| Snowflake Inc | United States | 84,570 | -0.87 | 71.5 | 0.1 |
| DoorDash Inc | United States | 67,743 | -0.19 | 17.6 | -22.9 |
| Roku Inc | United States | 59,111 | -0.26 | 23.1 | -21.4 |
| Bilibili Inc | China | 51,601 | -4.76 | 18.2 | -29.8 |
| Teladoc Health Inc | United States | 41,124 | -0.30 | 20.3 | -9.9 |
| XPeng Inc | China | 37,228 | -2.41 | 15.0 | 13.9 |
| Affirm Holdings Inc | United States | 34,499 | -0.89 | 39.7 | -5.8 |
| BeiGene Ltd | China | 34,490 | -9.78 | 35.8 | -15.1 |
| Unity Software Inc | United States | 34,299 | -0.35 | 32.7 | 13.7 |
| Plug Power Inc | United States | 32,156 | -0.18 | 68.1 | 15.0 |
| Seagen Inc | United States | 31,016 | -0.11 | 15.9 | 14.0 |
| Cloudflare Inc | United States | 28,050 | -0.08 | 46.1 | 2.6 |
| Splunk Inc | United States | 27,486 | -0.21 | 10.8 | 20.7 |
| MongoDB Inc | United States | 25,201 | -0.98 | 34.1 | -5.1 |
| Exact Sciences Corp | United States | 24,752 | -1.14 | 13.3 | 6.4 |
| GSX Techedu Inc | China | 24,455 | -3.34 | 11.8 | -32.1 |
| Farfetch Ltd | United Kingdom | 23,465 | -0.66 | 10.3 | -11.9 |
| DraftKings Inc | United States | 23,186 | -1.16 | 26.5 | 4.5 |
| GDS Holdings Ltd | China | 20,998 | -0.15 | 18.6 | -1.8 |
| 10X Genomics Inc | United States | 20,458 | -0.32 | 38.9 | -16.1 |
| Argenx SE | Netherlands | 19,397 | -10.72 | 105.2 | -12.6 |
| Alnylam Pharmaceuticals Inc | United States | 19,214 | -4.77 | 21.0 | 3.6 |
| Ping An Healthcare and Technology Co Ltd | China | 18,942 | -0.91 | 11.6 | 2.7 |
| Innovent Biologics Inc | China | 18,305 | -0.61 | 24.0 | 9.0 |
| Guardant Health Inc | United States | 16,826 | -1.50 | 40.5 | -6.9 |
| Zai Lab Ltd | China | 15,781 | -2.52 | 87.5 | -12.5 |
| Kingsoft Cloud Holdings Ltd | China | 15,710 | -2.56 | 9.6 | -22.4 |
| Yatsen Holding Ltd | China | 15,665 | -1.17 | 10.7 | -7.0 |
| Oak Street Health Inc | United States | 15,461 | -0.46 | 11.1 | 0.8 |
| C3.ai Inc | United States | 15,370 | -0.79 | 69.6 | -12.5 |
| Bill.com Holdings Inc | United States | 15,319 | -0.19 | 57.4 | -6.7 |
| Canopy Growth Corp | Canada | 15,279 | -0.90 | 24.2 | -8.4 |
| Appian Corp | United States | 15,229 | -0.40 | 43.3 | -52.9 |
| Avalara Inc | United States | 14,770 | -0.16 | 21.3 | 18.3 |
| Elastic NV | United States | 14,429 | -0.44 | 20.6 | -1.0 |
| Cree Inc | United States | 14,240 | -0.59 | 21.3 | -21.1 |
| Aggregate / mean | 1,565,141 | 30.7 | -6.5 |
Source: Bloomberg and Saxo Grop
The red thread is that the list is dominated by US and Chinese stocks with the majority within biotechnology, software, media, and gaming. The combined market value for this group is stunningly $1.6trn but even more usual, the average price target is 6.5% below the current price which is something that rarely happens in equity markets as equity analysts typically have a positive bias in their recommendations and price targets. The average forward EV/Sales ratio is 30.7x which is around 10 times higher than the S&P 500 which is one of the most expensive equity indices in the world.
While January performance in equities was driven green transformation and biotechnology stocks, this month so far has been about e-commerce and bubble stocks with the latter segment up 11.2% month-to-date. In our team, we have tried the past couple of days to strike a tone of caution with financial conditions maxing out to the positive side and thus we think reality could begin to disappoint a bit against expectations. If interest rates continue higher, which we expect due to reflation, then the bubble stocks presented here pose a significant downside risk.
2024: The wasted year
Markets are driven by election optimism, overshadowing growing debt and liquidity concerns. The 2024 elections loom large, but economic fundamentals and debt issues warrant cautious investment.
As US economic slowdown hints at a shift away from exceptionalism, USD faces downside with looming Fed cuts. AUD and NZD set to outperform as their rate cuts lag. JPY gains on carry unwind bets and BOJ pivot.
Amid AI and obesity drug excitement, equities see varied prospects: neutral on overvalued US stocks, negative on Japan due to JPY risks, positive on Europe. European defence stocks gain appeal.
With the economic slowdown, quality assets will gain favour, especially sovereign bonds up to 5 years. Central banks' potential rate cuts in Q2 suggest extending duration, despite policy and inflation concerns.
Commodities poised for rebound. The "Year of the Metal" boosts gold and silver, copper awaits rate cuts. Grains may recover, natural gas stabilises. Gold targets $2,300-$2,500/oz, copper's breakout could signal growth.
Markets are driven by election optimism, overshadowing growing debt and liquidity concerns. The 2024 elections loom large, but economic fundamentals and debt issues warrant cautious investment.
As US economic slowdown hints at a shift away from exceptionalism, USD faces downside with looming Fed cuts. AUD and NZD set to outperform as their rate cuts lag. JPY gains on carry unwind bets and BOJ pivot.
Amid AI and obesity drug excitement, equities see varied prospects: neutral on overvalued US stocks, negative on Japan due to JPY risks, positive on Europe. European defence stocks gain appeal.
With the economic slowdown, quality assets will gain favour, especially sovereign bonds up to 5 years. Central banks' potential rate cuts in Q2 suggest extending duration, despite policy and inflation concerns.
Commodities poised for rebound. The "Year of the Metal" boosts gold and silver, copper awaits rate cuts. Grains may recover, natural gas stabilises. Gold targets $2,300-$2,500/oz, copper's breakout could signal growth.
